119 related articles for article (PubMed ID: 19644152)
1. Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas.
Urbaniak-Kujda D; Kapelko-Słowik K; Wołowiec D; Dybko J; Hałoń A; Jaźwiec B; Maj J; Jankowska-Konsur A; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2009 Jul; 63():355-9. PubMed ID: 19644152
[TBL] [Abstract][Full Text] [Related]
2. Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein.
Korecka-Polak A; Duszota A; Wierzbicki P; Niemczyk M; Bocian K; Kłosowska D; Paczek L; Górski A; Korczak-Kowalska G
Transplant Proc; 2011 Oct; 43(8):2917-21. PubMed ID: 21996189
[TBL] [Abstract][Full Text] [Related]
3. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
[TBL] [Abstract][Full Text] [Related]
4. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity.
Slowik M; Urbaniak-Kujda D; Bohdanowicz-Pawlak A; Kapelko-Slowik K; Dybko J; Wolowiec D; Jazwiec B; Daroszewski J
Endocr Res; 2012; 37(2):89-95. PubMed ID: 22489922
[TBL] [Abstract][Full Text] [Related]
5. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of CD8(+) and CD8(+)CD28(-) cell subsets in patients with hepatocellular carcinoma].
Qiu YR; Yang CL; Chen LB; Wang Q
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):72-3. PubMed ID: 12390853
[TBL] [Abstract][Full Text] [Related]
7. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
[TBL] [Abstract][Full Text] [Related]
8. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion.
Scala E; Russo G; Cadoni S; Narducci MG; Girardelli CR; De Pità O; Puddu P
J Invest Dermatol; 1999 Oct; 113(4):622-7. PubMed ID: 10504451
[TBL] [Abstract][Full Text] [Related]
9. Expansions of CD8+CD28- and CD8+TcRVbeta5.2+ T cells in peripheral blood of heavy alcohol drinkers.
Arosa FA; Porto G; Cabeda JM; Lacerda R; Resende D; Cruz E; Cardoso C; Fonseca M; Simões C; Rodrigues P; Bravo F; Oliveira JC; Alves H; Fraga J; Justiça B; de Sousa M
Alcohol Clin Exp Res; 2000 Apr; 24(4):519-27. PubMed ID: 10798589
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
11. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor.
Berger CL; Longley BJ; Imaeda S; Christensen I; Heald P; Edelson RL
Int J Cancer; 1998 May; 76(3):304-11. PubMed ID: 9579563
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease.
Borowitz MJ; Weidner A; Olsen EA; Picker LJ
Leukemia; 1993 Jun; 7(6):859-63. PubMed ID: 7684799
[TBL] [Abstract][Full Text] [Related]
15. Analysis of CD8+CD28- T-suppressor cells in gastric cancer patients.
Shen Y; Qu QX; Zhu YB; Zhang XG
J Immunoassay Immunochem; 2012; 33(2):149-55. PubMed ID: 22471605
[TBL] [Abstract][Full Text] [Related]
16. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
Jakob T; Neuber K; Altenhoff J; Kowalzick L; Ring J
Acta Derm Venereol; 1996 Jan; 76(1):34-6. PubMed ID: 8721488
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma.
Asadullah K; Friedrich M; Döcke WD; Jahn S; Volk HD; Sterry W
J Invest Dermatol; 1997 May; 108(5):743-7. PubMed ID: 9129226
[TBL] [Abstract][Full Text] [Related]
18. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
[TBL] [Abstract][Full Text] [Related]
19. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
20. Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma.
Campillo JA; Martínez-Escribano JA; Minguela A; López-Alvarez R; Marín LA; García-Alonso AM; Bensussan A; Alvarez-López MR
Dermatology; 2007; 214(4):283-8. PubMed ID: 17460398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
